Citation

Hassani V, Amniati S, Kashaninasab F, Niakan M, Moradi Moghadam O, Jafarian AA, Farahmand Rad R, Sehat-Kashani S, Habibi A. Anesth. Pain Med. 2020; 10(6): e107513.

Copyright

(Copyright © 2020, KOWSAR)

DOI

10.5812/aapm.107513

PMID

34150573

Abstract

Electroconvulsive therapy (ECT) was first experienced in 1938 and had been conducting without anesthesia for 30 years. In this study, the most common indication for ECT was mood disorder (major depressive disorder and bipolar I disorder). We introduce a patient with a history of COVID-19 and suicide who required emergency ECT. Electroconvulsive therapy can be life-saving in patients with suicide history or catatonic schizophrenia. Health workers are at the front line of the COVID-19 outbreak control and must follow health instructions. Aerosol-producing procedures such as suction in anesthesia for ECT may facilitate the transmission of infectious diseases such as COVID-19. When performing aerosol-producing procedures during the pandemic of novel coronavirus, every patient should be considered suspicious.

Language: en

Keywords

Suicide; COVID-19; SARS-CoV-2; Electroconvulsive Therapy